Showing 15 posts of 771 posts found.


Gilead agrees to pay $97 million to settle Medicare kickbacks case

September 24, 2020
Business Services Gilead, Medicare, drugs, kickbacks

Gilead has agreed to pay $97 million to resolve claims from the US Government that it used an independent charity …

Leading pharmaceutical companies sued in US for conspiring to drive up generics prices

June 11, 2020
Business Services drugs, generics, lawsuit, price fixing, price-fixing

26 pharmaceutical companies are being sued by most US states for allegedly conspiring to reduce competition and drive up generic …

Coronavirus pandemic puts UK’s post-Brexit drug stockpile at risk

June 8, 2020
Sales and Marketing COVID-19, coronavirus, drugs

The pharmaceutical industry has warned the UK government that certain stockpiles of medicine have been used up due to the …


India considering export restrictions on antibiotics due to coronavirus

February 17, 2020
Sales and Marketing Chinese Coronavirus, Indian Pharma, Wuhan, china coronavirus, coronavirus, drugs

The Indian government is considering an export ban on antibiotics, vitamins and hormones due to the lockdown of Hubei province, …


Global drug market’s production line threatened by coronavirus

February 14, 2020
Medical Communications Chinese Coronavirus, Drug markets, Wuhan Coronavirus, china epidemic, coronavirus, drugs, epidemic, pharma

The global drug market is facing issues over production due to the coronavirus ravaging the supply line from China. In …


Idorsia reveals it is working with Neurocrine on new epilepsy drug deal

January 10, 2020
Medical Communications FDA, Idorsia, Neurocrine, drugs, epilepsy, pharma

Idorsia revealed its 2019 deal for its investigational epilepsy medicine was with Neurocrine Biosciences, and it is potentially worth more …


Novartis’ $2.15m SMA drug Zolgensma becomes most expensive FDA-approved therapy

May 28, 2019
Manufacturing and Production AveXis, FDA, Zolgensma, access, drugs, pricing, sma

The FDA has approved Novartis subsidiary AveXis’ $2.15 million gene therapy Zolgensma for children with spinal muscular atrophy (SMA). The …


Patients to recieve MDMA-assisted psychotherapy on ‘compassionate’ grounds in Israel

February 28, 2019
Research and Development MDMA, PTSD, drugs, mental health, psychedelics

The Israeli Health Ministry has approved the compassionate use of MDMA-assisted psychotherapy for 50 patients with post-traumatic stress disorder (PTSD). …


UK launches drug testing service for illicit drugs

February 25, 2019
Sales and Marketing Home office, UK, cocaine, drugs, fentanyl, illicit substances, recreational drugs

The UK Home Office have licensed a drug-checking service for users of illicit substances. The yearlong pilot project, run by …

Teva settles ‘pay-to-delay’ case with FTC

February 21, 2019
Business Services, Sales and Marketing FTC, Teva, antitrust, drugs, generics, monopoly

Teva Pharmaceuticals has settled a dispute with the Federal Trade Commission (FTC) over three separate federal court antitrust lawsuits involving …


GSK announces results of three year trial into long-lasting HIV injection

October 30, 2018
Manufacturing and Production GSK, HIV, drugs, injection, medication

GlaxoSmithKline have announced the results of a three year investigation into a long acting, injectable, two-drug HIV regimen at the …


President Trump pledges to fight drug addiction at UN meeting

September 25, 2018
Manufacturing and Production Trump, UN, drugs, illicit drugs, trafficking

President Donald Trump has pledged to fight “the scourge of drug addiction,” as he outlined his commitment to the fight …


Life expectancy falls in America; drugs, alcohol and suicide to blame

September 24, 2018
Sales and Marketing USA, alcohol, drugs, health, opiod crisis, suicide

Life expectancy has fallen for the second year in a row for people in the United States, according to new …


PTC Therapeutics’ results in SMA has Biogen nervous

June 19, 2018
Manufacturing and Production, Research and Development Biogen, PTC Therapeutics, biotech, drugs, pharma, pharmaceutical

Biogen currently has the only product on the market approved to treat spinal muscular atrophy (SMA), in Spinraza, and that …


Roche buys out rest of Foundation Medicine for $2.4bn

June 19, 2018
Manufacturing and Production, Sales and Marketing Foundation Medicine, Roche, biotech, drugs, pharma, pharmaceutical

Roche has clearly seen significant potential in Foundation Medicine’s work in genomics to pay $2.4 billion to take complete ownership …

Latest content